Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Ri, Cui"'
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract Homeobox B8 (HOXB8) belongs to the HOX family and was essential to the development of colorectal carcinoma. Among the prevalent monoclonal antibodies for treating RAS/BRAF wild-type metastatic colorectal cancer (mCRC) patients, cetuximab sta
Externí odkaz:
https://doaj.org/article/6d5d6705b4eb4f60ad64aeed2ea8d3fe
Autor:
Lianli Ni, Xinping Zhu, Qi Zhao, Yiwei Shen, Lu Tao, Ji Zhang, Han Lin, Weishan Zhuge, Young-Chang Cho, Ri Cui, Wangyu Zhu
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 51, Iss , Pp 100991- (2024)
Dihydroartemisinin (DHA) exerts an anti-tumor effect in multiple cancers, however, the molecular mechanism of DHA and whether DHA facilitates the anti-tumor efficacy of cisplatin in non-small cell lung cancer (NSCLC) are unclear. Here, we found that
Externí odkaz:
https://doaj.org/article/d6b4acffc0d9427b99355efac9fc43ad
Autor:
Chenyu Qiu, Xin Shen, Hui Lu, Yinghua Chen, Chenxin Xu, Peisen Zheng, Yiqun Xia, Junqi Wang, Yafei Zhang, Shaotang Li, Peng Zou, Ri Cui, Jundixia Chen
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-13 (2023)
Abstract Colon cancer is a major cause of cancer-related death. Despite recent improvements in the treatment of colon cancer, new strategies to improve the overall survival of patients are urgently needed. Heat shock protein 90 (HSP90) is widely reco
Externí odkaz:
https://doaj.org/article/a5ade6b0b6164caf8d3bc09549c2dd2b
Autor:
Wangyu Zhu, Yun Yu, Yuxin Ye, Xinyue Tu, Yan Zhang, Tao Wu, Lianli Ni, Xiangjie Huang, Yumin Wang, Ri Cui
Publikováno v:
Translational Oncology, Vol 37, Iss , Pp 101755- (2023)
Background: Our recent study found that QKI-5 regulated miRNA, miR-196b-5p, promotes non-small cell lung cancer (NSCLC) progression by directly targeting GATA6, TSPAN12 and FAS. However, the biological functions of miR-196b-5p in NSCLC progression an
Externí odkaz:
https://doaj.org/article/5227be1b30cb4591a3cd689db2e739e1
Autor:
Wangyu Zhu, Yun Yu, Kexin Fang, Sisi Xiao, Lianli Ni, Changtian Yin, Xiangjie Huang, Xinchen Wang, Yongkui Zhang, Han‐Bo Le, Ri Cui
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4590-4604 (2023)
Abstract Background RNA‐binding protein Quaking‐5 (QKI‐5), a major isoform of QKIs, inhibits tumor progression in non‐small cell lung cancer (NSCLC). However, the underlying molecular mechanisms of QKI‐5 in the cell cycle of NSCLC are still
Externí odkaz:
https://doaj.org/article/5037118217694dfb8cbe3d02bb84548e
Autor:
Hehuan Sui, Sisi Xiao, Suping Jiang, Siyuan Wu, Haizhen Lin, Liyuan Cheng, Lihua Ye, Qi Zhao, Yun Yu, Lu Tao, Feng-Ming Kong, Xiaoying Huang, Ri Cui
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 39, Iss , Pp 100897- (2023)
Lung cancer is one of the most commonly diagnosed cancers worldwide. Although cisplatin-based chemotherapy regimens serve a pivotal role in non-small cell lung cancer (NSCLC) treatment, drug resistance and serious side effects limited its further cli
Externí odkaz:
https://doaj.org/article/1c68055134494322810652d1f1073a18
Autor:
Qianqian Zhang, Weiqian Chen, Xiuling Lv, Qiaoyou Weng, Minjiang Chen, Ri Cui, Guang Liang, Jiansong Ji
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/e597c9600dbd4ec4829d5801e5bf1f2f
Autor:
Fengjiao Wu, Rongrong Shao, Peisen Zheng, Tingting Zhang, Chenyu Qiu, Hehuan Sui, Shaotang Li, Libo Jin, Huanle Pan, Xiance Jin, Peng Zou, Ri Cui, Congying Xie
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Colon cancer is one of the most common cancer in the world. Doxorubicin (DOX) is a classical anti-tumor drug which widely used in treatment of cancers, however, high toxicity limited its further clinical application. Thus, it is urgent to find new dr
Externí odkaz:
https://doaj.org/article/4d82af278d764999b89e0fe8945bf99e
Autor:
Weiqian Chen, Peng Zou, Zhongwei Zhao, Xi Chen, Xiaoxi Fan, Rajamanickam Vinothkumar, Ri Cui, Fazong Wu, Qianqian Zhang, Guang Liang, Jiansong Ji
Publikováno v:
Redox Biology, Vol 48, Iss , Pp 102191- (2021)
Externí odkaz:
https://doaj.org/article/6511cf9962c54beab9948dcb8ade8e89
Autor:
Lihua Wang, Canwei Wang, Zheying Tao, Liqian Zhao, Zheng Zhu, Wencan Wu, Ye He, Hong Chen, Bin Zheng, Xiangjie Huang, Yun Yu, Linjun Yang, Guang Liang, Ri Cui, Tongke Chen
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-17 (2019)
Abstract Background Breast cancer is the most prevalent cancer among women worldwide. WZ35, an analog of curcumin, has been demonstrated to remarkably improve the pharmacokinetic profiles in vivo compared with curcumin. WZ35 exhibits promising antitu
Externí odkaz:
https://doaj.org/article/5042010b1eee4ab5af2c58ebe9a4eccd